Overview

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in patients with high cholesterol.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Ezetimibe, Simvastatin Drug Combination
Niacin
Niacinamide
Nicotinic Acids
Simvastatin